Live from the NIH registry
Studies recruiting near McKinney right now
Top 25 of 457 recruiting studies, sorted by proximity — each links to its official registry page
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Phase 3
Interventional 428 participants sought
UT Southwestern Clinical Center at Richardson/Plano — Richardson, Texas (17.9 mi)
· Sponsor: NRG Oncology
Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
Neuromyelitis Optica Spectrum Disorder, NMOSD
N/A
Observational 200 participants sought
Clinical Trial Site — Plano, Texas (12.7 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion
Left Atrial Appendage Closure
N/A
Interventional 444 participants sought
Baylor Scott and White Heart Hospital — Plano, Texas (12.7 mi)
· Sponsor: Baylor Research Institute
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Diffuse Cutaneous Systemic Sclerosis
Phase 2
Interventional 200 participants sought
Arthritis and Rheumatology Ins — Allen, Texas (6.8 mi)
· Sponsor: Novartis Pharmaceuticals
FORWARD CAD IDE Study
Coronary Arterial Disease (CAD)
N/A
Interventional 408 participants sought
Baylor Scott and White - The Heart Hospital Baylor Plano — Plano, Texas (12.7 mi)
· Sponsor: Shockwave Medical, Inc.
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Texas Oncology - Northeast Texas ( Site 8002) — Flower Mound, Texas (28.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Texas Oncology-Northeast Texas — McKinney, Texas (3.0 mi)
· Sponsor: Pfizer
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress
Phase 2
Interventional 360 participants sought
Seaport Investigator Site — Richardson, Texas (17.9 mi)
· Sponsor: Seaport Therapeutics
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
N/A
Interventional 290 participants sought
Metroplex Pulmonary & Sleep Center — McKinney, Texas (3.0 mi)
· Sponsor: Philip Morris Products S.A.
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
DFW Clinical Trials — Carrollton, Texas (21.5 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
Muscular Atrophy, Spinal
Phase 3
Interventional 30 participants sought
Neurology Rare Disease Center — Flower Mound, Texas (28.0 mi)
· Sponsor: Biogen
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Tekton Research — McKinney, Texas (3.0 mi)
· Sponsor: Medtronic MiniMed, Inc.
The Ailliance Post-Market Clinical Study
Spinal Deformity, Spinal Degenerative Disorder
N/A
Interventional 1,000 participants sought
American Neurospine Institute, PLLC — Frisco, Texas (9.7 mi)
· Sponsor: Medtronic Spinal and Biologics
Acceptability and Efficacy of GO MOVE
Cerebral Palsy, Hemiplegic Cerebral Palsy
N/A
Interventional 50 participants sought
Scottish Rite for Children — Frisco, Texas (9.7 mi)
· Sponsor: Texas Scottish Rite Hospital for Children
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
UT Southwestern Clinical Center at Richardson/Plano — Richardson, Texas (17.9 mi)
· Sponsor: NRG Oncology
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
University of Texas Southwestern Simmons Cancer Center - Richardson/Plano — Richardson, Texas (17.9 mi)
· Sponsor: Pfizer
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
Schizophrenia
Phase 2
Interventional 268 participants sought
Pillar Clinical Research - Richardson /ID# 275715 — Richardson, Texas (17.9 mi)
· Sponsor: AbbVie
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
DelRicht Clinical Research - McKinney — Prosper, Texas (8.1 mi)
· Sponsor: Ardelyx
Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator
Cardiomyopathies, Heart Failure
N/A
Interventional 300 participants sought
CardioVoyage — McKinney, Texas (3.0 mi)
· Sponsor: Zoll Medical Corporation
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Myositis
Phase 3
Interventional 318 participants sought
Arthritis & Rheumatology Research Institute, PLLC — Frisco, Texas (9.7 mi)
· Sponsor: Pfizer
Prospective Long-Term Outcomes of a Standardized Ross Procedure
Aortic Valve Disease
N/A
Observational 225 participants sought
Baylor Scott and White Heart Hospital — Plano, Texas (12.7 mi)
· Sponsor: Baylor Research Institute
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Overweight, Obesity
Phase 3
Interventional 900 participants sought
Medrasa Clinical Research — Wylie, Texas (14.9 mi)
· Sponsor: Eli Lilly and Company
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Prosper, Texas (8.1 mi)
· Sponsor: Axsome Therapeutics, Inc.
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
UT Southwestern Clinical Center at Richardson/Plano — Richardson, Texas (17.9 mi)
· Sponsor: SWOG Cancer Research Network
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
UT Southwestern Clinical Center at Richardson/Plano — Richardson, Texas (17.9 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group